+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biologics - Global Market Trajectory & Analytics

  • ID: 5140927
  • Report
  • September 2020
  • Region: Global
  • 187 pages
  • Global Industry Analysts, Inc
1 of 2
Global Biologics Market to Reach $505.6 Billion by 2027

Amid the COVID-19 crisis, the global market for Biologics estimated at US$292.2 Billion in the year 2020, is projected to reach a revised size of US$505.6 Billion by 2027, growing at a CAGR of 8.1% over the analysis period 2020-2027. Recombinant Therapeutic Proteins, one of the segments analyzed in the report, is projected to record a 8.8% CAGR and reach US$187.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Blood & Blood components segment is readjusted to a revised 7.5% CAGR for the next 7-year period.

The U. S. Market is Estimated at $86.5 Billion, While China is Forecast to Grow at 7.6% CAGR

The Biologics market in the U. S. is estimated at US$86.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$87.8 Billion by the year 2027 trailing a CAGR of 7.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.6% and 6.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.

Cellular & Gene Therapy Segment to Record 6.1% CAGR

In the global Cellular & Gene Therapy segment, USA, Canada, Japan, China and Europe will drive the 6.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$48.3 Billion in the year 2020 will reach a projected size of US$73.3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$58.2 Billion by the year 2027. We bring years of research experience to this 9th edition of our report. The 187-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:
  • AbbVie, Inc.
  • Amgen, Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Janssen Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer, Inc.
Note: Product cover images may vary from those shown
2 of 2
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Global Competitor Market Shares
  • Biologics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: Biologics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 2: Biologics Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
  • TABLE 3: Biologics Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
  • TABLE 4: Recombinant Therapeutic Proteins (Product Type) World Market by Region/Country in US$ Million: 2020 to 2027
  • TABLE 5: Recombinant Therapeutic Proteins (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
  • TABLE 6: Recombinant Therapeutic Proteins (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 7: Blood & Blood components (Product Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
  • TABLE 8: Blood & Blood components (Product Type) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
  • TABLE 9: Blood & Blood components (Product Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
  • TABLE 10: Cellular & Gene Therapy (Product Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
  • TABLE 11: Cellular & Gene Therapy (Product Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
  • TABLE 12: Cellular & Gene Therapy (Product Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 13: Vaccines (Product Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
  • TABLE 14: Vaccines (Product Type) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
  • TABLE 15: Vaccines (Product Type) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 16: Infectious Diseases (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 17: Infectious Diseases (Application) Global Historic Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 18: Infectious Diseases (Application) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 19: Oncology (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027
  • TABLE 20: Oncology (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019
  • TABLE 21: Oncology (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
  • TABLE 22: Autoimmune Diseases (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
  • TABLE 23: Autoimmune Diseases (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 24: Autoimmune Diseases (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
  • TABLE 25: Diabetes (Application) Worldwide Sales in US$ Million by Region/Country: 2020-2027
  • TABLE 26: Diabetes (Application) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019
  • TABLE 27: Diabetes (Application) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027
  • TABLE 28: Other Applications (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020-2027
  • TABLE 29: Other Applications (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2012-2019
  • TABLE 30: Other Applications (Application) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
  • Market Facts & Figures
  • US Biologics Market Share (in %) by Company: 2019 & 2025
  • Market Analytics
  • TABLE 31: United States Biologics Market Estimates and Projections in US$ Million by Product Type: 2020 to 2027
  • TABLE 32: Biologics Market in the United States by Product Type: A Historic Review in US$ Million for 2012-2019
  • TABLE 33: United States Biologics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
  • TABLE 34: United States Biologics Latent Demand Forecasts in US$ Million by Application: 2020 to 2027
  • TABLE 35: Biologics Historic Demand Patterns in the United States by Application in US$ Million for 2012-2019
  • TABLE 36: Biologics Market Share Breakdown in the United States by Application: 2012 VS 2020 VS 2027
CANADA
  • TABLE 37: Canadian Biologics Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
  • TABLE 38: Canadian Biologics Historic Market Review by Product Type in US$ Million: 2012-2019
  • TABLE 39: Biologics Market in Canada: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027
  • TABLE 40: Canadian Biologics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
  • TABLE 41: Biologics Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
  • TABLE 42: Canadian Biologics Market Share Analysis by Application: 2012 VS 2020 VS 2027
JAPAN
  • TABLE 43: Japanese Market for Biologics: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
  • TABLE 44: Biologics Market in Japan: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
  • TABLE 45: Japanese Biologics Market Share Analysis by Product Type:2012 VS 2020 VS 2027
  • TABLE 46: Japanese Demand Estimates and Forecasts for Biologics in US$ Million by Application: 2020 to 2027
  • TABLE 47: Japanese Biologics Market in US$ Million by Application: 2012-2019
  • TABLE 48: Biologics Market Share Shift in Japan by Application:2012 VS 2020 VS 2027
CHINA
  • TABLE 49: Chinese Biologics Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
  • TABLE 50: Biologics Historic Market Analysis in China in US$ Million by Product Type: 2012-2019
  • TABLE 51: Chinese Biologics Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • TABLE 52: Chinese Demand for Biologics in US$ Million by Application: 2020 to 2027
  • TABLE 53: Biologics Market Review in China in US$ Million by Application: 2012-2019
  • TABLE 54: Chinese Biologics Market Share Breakdown by Application:2012 VS 2020 VS 2027
EUROPE
  • Market Facts & Figures
  • European Biologics Market: Competitor Market Share Scenario (in %) for 2019 & 2025
  • Market Analytics
  • TABLE 55: European Biologics Market Demand Scenario in US$ Million by Region/Country: 2020-2027
  • TABLE 56: Biologics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
  • TABLE 57: European Biologics Market Share Shift by Region/Country:2012 VS 2020 VS 2027
  • TABLE 58: European Biologics Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
  • TABLE 59: Biologics Market in Europe in US$ Million by Product Type: A Historic Review for the Period 2012-2019
  • TABLE 60: European Biologics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
  • TABLE 61: European Biologics Addressable Market Opportunity in US$ Million by Application: 2020-2027
  • TABLE 62: Biologics Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
  • TABLE 63: European Biologics Market Share Analysis by Application:2012 VS 2020 VS 2027
FRANCE
  • TABLE 64: Biologics Market in France by Product Type: Estimates and Projectionsin US$ Million for the Period 2020-2027
  • TABLE 65: French Biologics Historic Market Scenario in US$ Million by Product Type: 2012-2019
  • TABLE 66: French Biologics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
  • TABLE 67: Biologics Quantitative Demand Analysis in France in US$ Million by Application: 2020-2027
  • TABLE 68: French Biologics Historic Market Review in US$ Million by Application: 2012-2019
  • TABLE 69: French Biologics Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
GERMANY
  • TABLE 70: Biologics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2020-2027
  • TABLE 71: German Biologics Historic Market Analysis in US$ Million by Product Type:2012-2019
  • TABLE 72: German Biologics Market Share Breakdown by Product Type:2012 VS 2020 VS 2027
  • TABLE 73: Biologics Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020-2027
  • TABLE 74: German Biologics Market in Retrospect in US$ Million by Application: 2012-2019
  • TABLE 75: Biologics Market Share Distribution in Germany by Application:2012 VS 2020 VS 2027
ITALY
  • TABLE 76: Italian Biologics Market Growth Prospects in US$ Million by Product Type for the Period 2020-2027
  • TABLE 77: Biologics Historic Market Analysis in Italy in US$ Million by Product Type:2012-2019
  • TABLE 78: Italian Biologics Market by Product Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
  • TABLE 79: Italian Demand for Biologics in US$ Million by Application: 2020 to 2027
  • TABLE 80: Biologics Market Review in Italy in US$ Million by Application: 2012-2019
  • TABLE 81: Italian Biologics Market Share Breakdown by Application:2012 VS 2020 VS 2027
UNITED KINGDOM
  • TABLE 82: United Kingdom Market for Biologics: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2020-2027
  • TABLE 83: Biologics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product Type for the Period 2012-2019
  • TABLE 84: United Kingdom Biologics Market Share Analysis by Product Type:2012 VS 2020 VS 2027
  • TABLE 85: United Kingdom Demand Estimates and Forecasts for Biologics in US$ Million by Application: 2020 to 2027
  • TABLE 86: United Kingdom Biologics Market in US$ Million by Application: 2012-2019
  • TABLE 87: Biologics Market Share Shift in the United Kingdom by Application:2012 VS 2020 VS 2027
REST OF EUROPE
  • TABLE 88: Rest of Europe Biologics Market Estimates and Forecasts in US$ Million by Product Type: 2020-2027
  • TABLE 89: Biologics Market in Rest of Europe in US$ Million by Product Type: A Historic Review for the Period 2012-2019
  • TABLE 90: Rest of Europe Biologics Market Share Breakdown by Product Type: 2012 VS 2020 VS 2027
  • TABLE 91: Rest of Europe Biologics Addressable Market Opportunity in US$ Million by Application: 2020-2027
  • TABLE 92: Biologics Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012-2019
  • TABLE 93: Rest of Europe Biologics Market Share Analysis by Application: 2012 VS 2020 VS 2027
ASIA-PACIFIC
  • TABLE 94: Biologics Market in Asia-Pacific by Product Type: Estimates and Projections in US$ Million for the Period 2020-2027
  • TABLE 95: Asia-Pacific Biologics Historic Market Scenario in US$ Million by Product Type: 2012-2019
  • TABLE 96: Asia-Pacific Biologics Market Share Analysis by Product Type: 2012 VS 2020 VS 2027
  • TABLE 97: Biologics Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020-2027
  • TABLE 98: Asia-Pacific Biologics Historic Market Review in US$ Million by Application: 2012-2019
  • TABLE 99: Asia-Pacific Biologics Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and 2027
REST OF WORLD
  • TABLE 100: Rest of World Biologics Market Estimates and Forecasts in US$ Million by Product Type: 2020 to 2027
  • TABLE 101: Rest of World Biologics Historic Market Review by Product Type in US$ Million: 2012-2019
  • TABLE 102: Biologics Market in Rest of World: Percentage Share Breakdown of Sales by Product Type for 2012, 2020, and 2027
  • TABLE 103: Rest of World Biologics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to 2027
  • TABLE 104: Biologics Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2012-2019
  • TABLE 105: Rest of World Biologics Market Share Analysis by Application:2012 VS 2020 VS 2027
IV. COMPETITION
  • Total Companies Profiled: 43
Note: Product cover images may vary from those shown
Adroll
adroll